March 27, 2026

ACSM Revises Resistance Training Guidance

Synthesized evidence clarifies which training variables enhance strength, hypertrophy, and performance.

Conexiant

March 26, 2026

Ultrasound Models Estimate Whole-Body Muscle Mass

New equations incorporating cross-sectional area improve estimation accuracy.

Conexiant

March 25, 2026

When Guillain-Barré Signals Lyme 

A case highlights how evolving neurologic findings can prompt testing for tick-borne infection.

Conexiant

March 25, 2026

Japan Clears First iPSC Therapies for Clinical Use 

Two iPSC-derived cell therapies receive time-limited authorization following early clinical trials

The Medicine Maker

March 23, 2026

MRI Identifies 3 Friedreich Ataxia Subtypes

Machine learning analysis of structural MRI reveals distinct patterns of neurodegeneration that vary in their association with disease severity

Conexiant

March 23, 2026

Fibromyalgia Drugs Tested for Value

Investigators compare common fibromyalgia therapies.

Conexiant

March 19, 2026

Lumbar Fusion: Two Decades of Change

Investigators find rising use of complex lumbar fusion procedures and increasing hospital costs in the US.

Conexiant

March 18, 2026

AAP, NASPGHAN Issue Guidance on Faltering Weight in Children

New recommendations standardize diagnosis and aim to reduce unnecessary interventions in early childhood growth concerns.

Conexiant

March 17, 2026

ALS Trial Tests Celecoxib–Ciprofloxacin Combination

Dual-drug therapy showed signals of slower disease progression and reduced complications in patients with ALS.

Conexiant

March 05, 2026

Calcium Strategy Following Thyroidectomy

Investigators compare routine prophylaxis vs postoperative parathyroid hormone-guided supplementation.

Conexiant